TGFB1 and neoplasm: Moreover, immunologically cold tumors for LGG and KIRC have better survival prognosis in comparison to immunologically hot tumors (52,53); this has generally been attributed to tumor signaling including pathways known to be associated with immune suppression such as transforming growth factor beta (TGFB) (91).